Irisin reduces inflammatory signaling pathways in inflammation-mediated metabolic syndrome.
Mol Cell Endocrinol
; 552: 111676, 2022 07 15.
Article
in En
| MEDLINE
| ID: mdl-35569582
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Metabolic Syndrome
/
Diabetes Mellitus, Type 2
Limits:
Humans
Language:
En
Journal:
Mol Cell Endocrinol
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: